Financials

  • Market Capitalization 4.57 B
  • Employee 755
  • Founded 2006
  • CEO N/A
  • Website www.veracyte.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2M542
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
51.34
Price to sales ratio
6.56

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1376
LEGN
Legend Biotech Corporation - American Depositary Shares
25.61 USD-5.43%-7.48%-29.43%-19.92%4.74 B USD
1386
EWTX
Edgewise Therapeutics, Inc. - Common Stock
41.63 USD-8.32%+3.69%+22.59%+173.34%4.48 B USD
1427
VKTX
Viking Therapeutics, Inc. - Common Stock
37.78 USD-2.78%-1.82%+32.56%+22.78%4.39 B USD
1436
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
25.46 USD-2.90%-1.43%+18.53%+21.64%4.36 B USD

Frequently asked questions about Veracyte, Inc. - Common Stock

What is the Veracyte, Inc. - Common Stock stock price today?

The current price of Veracyte, Inc. - Common Stock (VCYT) is 57.25. Over the past 24 hours, the stock has changed by +0.49%. Follow the VCYT chart for real-time price dynamics.

What is the stock ticker of Veracyte, Inc. - Common Stock?

Veracyte, Inc. - Common Stock trades under the ticker VCYT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Veracyte, Inc. - Common Stock stock going up?

VCYT has changed by -1.78% over the last week, +20.50% over the last month, and +55.15% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Veracyte, Inc. - Common Stock net income for the last quarter?

Veracyte, Inc. - Common Stock reported net income of 28.71 M for the last quarter. The previous quarter showed 41.15 M, which means net income changed by -30.24%.

How many employees does Veracyte, Inc. - Common Stock have?

As of the latest available data, Veracyte, Inc. - Common Stock has 755 employees. Workforce size can provide additional context about the company's scale and operations.

What is Veracyte, Inc. - Common Stock EBITDA?

Veracyte, Inc. - Common Stock EBITDA is 65.99 M, and its EBITDA margin is 47.45%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Veracyte, Inc. - Common Stock stock?

You can buy Veracyte, Inc. - Common Stock (VCYT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Veracyte, Inc. - Common Stock stock?

Investing in Veracyte, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VCYT chart and related analysis on metatrader.com as part of your research.

News